Akero Therapeutics

AKRO

AKRO Akero Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    AKRO Chart
    See on advanced chart >

    About

    Akero Therapeutics, Inc. was incorporated in January 2017 under the laws of the State of Delaware .They are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high...
    • Highlight
      A clinical-stage company that develops transformational treatments for serious metabolic diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/20/2019
    • Established Date
      Invalid Date
    • Full-time Employees
      56
    • Address
      601 Gateway Boulevard Suite 350 South San Francisco CA 94080
    • Tel
      1-650-4876488
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-19 23:21:18